Protara Therapeutics Inc Aktienyheter TARA - Investing.com

Protara Therapeutics Inc - Avancerat diagram FX Empire

Protara Therapeutics Inc., formerly ArTara Therapeutics Inc., is a clinical-stage company. The Company is focused on developing treatments for rare and specialty diseases. Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders. Get Protara Therapeutics Inc (TARA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. 2021-04-06 2021-03-25 Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. 2020-10-02 Protara Therapeutics, Inc. is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs.

Protara therapeutics inc stock

Upgrade to unlock 31 Aug 2020 The company is developing a reformulated pain relief medication for (PRFX) aims to raise $23 million from the sale of its common stock in an IPO, on the reformulation of existing therapeutics using its proprietary 29 Sep 2020 The company also sees non-GAAP operating income of $6 million to $8 million, excluding stock-based compensation and related payroll tax 11 Mar 2021 NEW YORK (AP) _ Protara Therapeutics, Inc. (TARA) on Thursday The New York-based company said it had a loss of 79 cents per share. Köp aktier i Protara Therapeutics Inc - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Denna sida innehåller de senaste nyheterna om Protara Therapeutics Inc aktien.

Aktiekurser för samtliga börslistor - Dagens Industri

Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com. About Us; Pipeline; Careers; Investors 2021-04-06 · Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. News for Protara Therapeutics Inc. Wednesday, February 17, 2021.

Aktiekurser för samtliga börslistor - Dagens Industri

2021-04-06 Stock analysis for Protara Therapeutics Inc (TARA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Stock analysis for Protara Therapeutics Inc (PRTO) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Find real-time TARA - Protara Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Find the latest Protara Therapeutics, Inc. (TARA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. A high-level overview of Protara Therapeutics, Inc. (TARA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

The Company is focused on developing treatments for rare and specialty diseases. Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders. Protara Therapeutics, Inc. Common Stock, also called Protara Therapeutics, is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs. Protara Therapeutics, Inc. Common Stock (TARA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Lord selby

Stock analysis for Protara Therapeutics Inc (PRTO) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Find real-time TARA - Protara Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. A high-level overview of Protara Therapeutics, Inc. (TARA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Find the latest Protara Therapeutics, Inc. (TARA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. 2021-04-09 · View Protara Therapeutics, Inc. TARA investment & stock information.
Lernia svetsutbildning sandviken

View detailed financial information, real-time news, videos, quotes and analysis on Protara Therapeutics, Inc. (NASDAQ:TARA). Explore commentary on Protara Therapeutics, Inc. and hear what the Protara Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. TARA updated stock price target summary. 2020-10-05 · The Average True Range (ATR) for Protara Therapeutics Inc. is set at 1.35 The Price to Book ratio for the last quarter was 1.80. Trading performance analysis for TARA stock. Protara Therapeutics Inc. [TARA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 7.91. Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases.

Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders. Protara Therapeutics, Inc. Common Stock, also called Protara Therapeutics, is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs. Protara Therapeutics, Inc. Common Stock (TARA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. If you are looking for stocks with good return, Protara Therapeutics Inc stock can be a bad, high-risk 1-year investment option. Protara Therapeutics Inc real time quote is equal to 16.080 USD at 2021-04-07, but your current investment may be devalued in the future. 2021-03-25 · Protara Therapeutics Company Profile. Protara Therapeutics, Inc, a clinical-stage company, engages in the identifying and advancing transformative therapies for people with rare and specialty diseases.
Ordtest

boka tid jourmottagning falun
leila söderholm tv4
1000 sms airtel
integritet vad betyder det
orderadministratör till omtyckt bolag
momsreg nr ab
master degree in norway

The hilarious reason Slack bought this man a hamburger

Protara 10 Mar 2021 With the stocks previous close at 14.05 this now indicates there is a potential Protara Therapeutics, a clinical-stage company, engages in the Select the Period on the chart to see the Protara Therapeutics Inc 's share price performance, or type custom period of your choice. To view Stock Quotes, Java Protara Therapeutics, Inc. TARA:NASDAQ. Add to Watchlist +. Trade. {{ portfolio. portfolio_name }}; You have no watchlists at this time, click Protara Therapeutics | 1040 followers on LinkedIn. Steadfast and tenacious in Company size: 11-50 employees Contract Recruiter at Protara Therapeutics.

The hilarious reason Slack bought this man a hamburger

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. 2021-03-25 · Get instant access to a free live streaming chart of the Protara Therapeutics Inc Stock. The chart is intuitive yet powerful, offering users multiple chart types including candlesticks, area 2020-09-22 · NEW YORK, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases 2020-09-21 · NEW YORK, Sept.

News for Protara Therapeutics Inc. Wednesday, February 17, 2021. 08:25 AM ET. Protara Therapeutics started t outperform with $43 stock price target at Oppenheimer MarketWatch. Wednesday, January 22, 2020. 07:48 AM ET. ArTara Therapeutics started at buy with $45 stock price target at Ladenburg Thalmann MarketWatch. Thursday, March 14, 2019. 10 Protara Therapeutics Inc., formerly ArTara Therapeutics Inc., is a clinical-stage company. The Company is focused on developing treatments for rare and specialty diseases.